GUMDROP : JHMI E1808 A Randomized Phase II Trial of Sunitinib and Gemcitabine or Sunitinib in Advanced Renal Cell Carcinoma with Sarcomatoid Features

Created by Channing Paller, last modified on Apr 14, 2012

Description:

Hist-confirmed RCC containing any sarcomatoid features; NO collecting duct or medullary carcinoma; measurable dx; NO prior systemic therapy for mets; NO pre-existing thyroid abnormality

Link: 

http://clinicaltrials.gov/ct2/show/NCT01164228

 

Site:

Johns Hopkins Hospital

Principal Investigator:

Jenny Kim, M.D.